ATE411024T1 - Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen - Google Patents

Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen

Info

Publication number: ATE411024T1
Authority: AT; Austria
Prior art keywords: desoxypeganine; intoxication; diseases; treatment; nervous system
Prior art date: 2001-04-24

Application number

AT02758191T

Other languages

English (en)

Inventor

Klaus Opitz

Joachim Moormann

Thomas Hille

Frank Becher

Original Assignee

Hf Arzneimittelforsch Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-24

Filing date

2002-04-18

Publication date

2008-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7682410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE411024(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-18 Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE411024T1 publication Critical patent/ATE411024T1/de

Links

WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title 1
210000003169 central nervous system Anatomy 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000035987 intoxication Effects 0.000 title 1
231100000566 intoxication Toxicity 0.000 title 1
230000000506 psychotropic effect Effects 0.000 title 1
239000000126 substance Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Addiction (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT02758191T 2001-04-24 2002-04-18 Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen ATE411024T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10119863A DE10119863A1 (de)	2001-04-24	2001-04-24	Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen

Publications (1)

Publication Number	Publication Date
ATE411024T1 true ATE411024T1 (de)	2008-10-15

Family

ID=7682410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02758191T ATE411024T1 (de)	2001-04-24	2002-04-18	Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen

Country Status (27)

Country	Link
US (1)	US20040132751A1 (de)
EP (1)	EP1383503B1 (de)
JP (1)	JP2004526791A (de)
KR (1)	KR20030094365A (de)
CN (1)	CN1638774A (de)
AR (1)	AR033469A1 (de)
AT (1)	ATE411024T1 (de)
AU (1)	AU2002325209B2 (de)
BR (1)	BR0209125A (de)
CA (1)	CA2445132C (de)
CZ (1)	CZ20032788A3 (de)
DE (2)	DE10119863A1 (de)
DK (1)	DK1383503T3 (de)
EA (1)	EA200301134A1 (de)
ES (1)	ES2316595T3 (de)
HU (1)	HUP0303921A3 (de)
IL (1)	IL158383A0 (de)
MX (1)	MXPA03009766A (de)
MY (1)	MY135676A (de)
NO (1)	NO20034741L (de)
NZ (1)	NZ529005A (de)
PL (1)	PL366845A1 (de)
PT (1)	PT1383503E (de)
SI (1)	SI1383503T1 (de)
SK (1)	SK287214B6 (de)
WO (1)	WO2002087553A2 (de)
ZA (1)	ZA200308042B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10354893B4 (de) *	2003-11-24	2011-03-10	Hf Arzneimittelforschung Gmbh	Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
DE10354894A1 (de) *	2003-11-24	2005-07-07	Hf Arzneimittelforschung Gmbh	Orale Formulierungen des Desoxypeganins und deren Anwendungen
ES2360547B1 (es) *	2009-11-02	2012-07-04	Consejo Superior De Investigaciones Científicas (Csic)	Procedimiento de obtención de los alcaloides activos de la planta medicinal peganum harmala y su uso.
US20220265582A1 (en) *	2021-02-24	2022-08-25	Universitätsspital Basel	Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3797494A (en) *	1969-04-01	1974-03-19	Alza Corp	Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) *	1971-08-09	1973-07-03	Alza Corp	Bandage for controlled release of vasodilators
US3996934A (en) *	1971-08-09	1976-12-14	Alza Corporation	Medical bandage
US4031894A (en) *	1975-12-08	1977-06-28	Alza Corporation	Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) *	1983-04-27	1986-03-27	Lohmann Gmbh & Co Kg, 5450 Neuwied	Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3843239C1 (de) *	1988-12-22	1990-02-22	Lohmann Therapie Syst Lts
US5602184A (en) *	1993-03-03	1997-02-11	The United States Of America As Represented By Department Of Health And Human Services	Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
DE19906979B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906974C2 (de) *	1999-02-19	2003-10-09	Lohmann Therapie Syst Lts	Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906977C1 (de) *	1999-02-19	2000-06-15	Lohmann Therapie Syst Lts	Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) *	1999-02-19	2004-04-15	Lts Lohmann Therapie-Systeme Ag	Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19924951B4 (de) *	1999-05-31	2004-02-05	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
CN1240384C (zh) *	1999-11-04	2006-02-08	美国爱科赛尔制药有限公司	石杉碱经皮给药制剂

2001
- 2001-04-24 DE DE10119863A patent/DE10119863A1/de not_active Withdrawn
2002
- 2002-04-18 DK DK02758191T patent/DK1383503T3/da active
- 2002-04-18 PL PL02366845A patent/PL366845A1/xx not_active IP Right Cessation
- 2002-04-18 US US10/475,788 patent/US20040132751A1/en not_active Abandoned
- 2002-04-18 ES ES02758191T patent/ES2316595T3/es not_active Expired - Lifetime
- 2002-04-18 HU HU0303921A patent/HUP0303921A3/hu unknown
- 2002-04-18 PT PT02758191T patent/PT1383503E/pt unknown
- 2002-04-18 AU AU2002325209A patent/AU2002325209B2/en not_active Ceased
- 2002-04-18 NZ NZ529005A patent/NZ529005A/en unknown
- 2002-04-18 WO PCT/EP2002/004278 patent/WO2002087553A2/de not_active Ceased
- 2002-04-18 CA CA002445132A patent/CA2445132C/en not_active Expired - Fee Related
- 2002-04-18 SK SK1316-2003A patent/SK287214B6/sk not_active IP Right Cessation
- 2002-04-18 KR KR10-2003-7013972A patent/KR20030094365A/ko not_active Ceased
- 2002-04-18 BR BR0209125-9A patent/BR0209125A/pt not_active IP Right Cessation
- 2002-04-18 CN CNA028088891A patent/CN1638774A/zh active Pending
- 2002-04-18 EA EA200301134A patent/EA200301134A1/ru unknown
- 2002-04-18 JP JP2002584899A patent/JP2004526791A/ja active Pending
- 2002-04-18 IL IL15838302A patent/IL158383A0/xx not_active IP Right Cessation
- 2002-04-18 EP EP02758191A patent/EP1383503B1/de not_active Expired - Lifetime
- 2002-04-18 SI SI200230779T patent/SI1383503T1/sl unknown
- 2002-04-18 CZ CZ20032788A patent/CZ20032788A3/cs unknown
- 2002-04-18 DE DE50212901T patent/DE50212901D1/de not_active Expired - Lifetime
- 2002-04-18 MX MXPA03009766A patent/MXPA03009766A/es active IP Right Grant
- 2002-04-18 AT AT02758191T patent/ATE411024T1/de not_active IP Right Cessation
- 2002-04-22 MY MYPI20021470A patent/MY135676A/en unknown
- 2002-04-24 AR ARP020101483A patent/AR033469A1/es unknown
2003
- 2003-10-16 ZA ZA200308042A patent/ZA200308042B/en unknown
- 2003-10-23 NO NO20034741A patent/NO20034741L/no unknown

Also Published As

Publication number	Publication date
HUP0303921A3 (en)	2011-03-28
CN1638774A (zh)	2005-07-13
EA200301134A1 (ru)	2004-04-29
SK287214B6 (sk)	2010-03-08
WO2002087553A3 (de)	2003-02-27
ZA200308042B (en)	2004-02-04
NZ529005A (en)	2007-11-30
CA2445132C (en)	2009-01-13
DE10119863A1 (de)	2002-11-07
SK13162003A3 (sk)	2004-02-03
HUP0303921A2 (hu)	2004-03-01
WO2002087553A2 (de)	2002-11-07
ES2316595T3 (es)	2009-04-16
DK1383503T3 (da)	2009-02-16
NO20034741D0 (no)	2003-10-23
US20040132751A1 (en)	2004-07-08
EP1383503A2 (de)	2004-01-28
NO20034741L (no)	2003-10-23
CA2445132A1 (en)	2002-11-07
CZ20032788A3 (en)	2004-05-12
HK1062402A1 (zh)	2004-11-05
SI1383503T1 (sl)	2009-04-30
PL366845A1 (en)	2005-02-07
IL158383A0 (en)	2004-05-12
AR033469A1 (es)	2003-12-17
MY135676A (en)	2008-06-30
DE50212901D1 (de)	2008-11-27
BR0209125A (pt)	2004-07-27
EP1383503B1 (de)	2008-10-15
AU2002325209B2 (en)	2007-08-16
JP2004526791A (ja)	2004-09-02
MXPA03009766A (es)	2005-04-19
KR20030094365A (ko)	2003-12-11
PT1383503E (pt)	2009-01-07

Legal Events

Date	Code	Title	Description
2012-01-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE316077T1 (de)	2006-02-15	Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
ATE518841T1 (de)	2011-08-15	Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas
DE602004022061D1 (de)	2009-08-27	Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
DE602004020072D1 (de)	2009-04-30	1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE602004028763D1 (de)	2010-09-30	Te zur behandlung von virenerkrankungen
DE60319865D1 (de)	2008-04-30	Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ATE390925T1 (de)	2008-04-15	Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE390407T1 (de)	2008-04-15	Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE524479T1 (de)	2011-09-15	Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
DE60328517D1 (de)	2009-09-03	Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
ATE440866T1 (de)	2009-09-15	Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE447551T1 (de)	2009-11-15	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE476414T1 (de)	2010-08-15	Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
ATE323680T1 (de)	2006-05-15	7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
DE602005015415D1 (de)	2009-08-27	N ausgewählter n-3-fettsäuren zur behandlung von erkrankungen des zentralen nervensystems
ATE542536T1 (de)	2012-02-15	3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
EP1117395A4 (de)	2002-08-14	Verbindungen zur behandlung von östrogenabhängigen erkrankungen und deren herstellungs und verwendungsmethoden
ATE418552T1 (de)	2009-01-15	Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE502006007982D1 (de)	2010-11-11	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE378052T1 (de)	2007-11-15	Verwendung von galanthamin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen
ATE289196T1 (de)	2005-03-15	Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE330596T1 (de)	2006-07-15	Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE411024T1 (de)	2008-10-15	Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen